<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2025.1631008</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>PipC affects the virulence of <italic>Salmonella enterica</italic> serovar <italic>Enteritidis</italic> and its deletion strain provides effective immune protection in mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Lu</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2930381/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Yubin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yan</surname> <given-names>Zhigang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Yuntai</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname> <given-names>Xiaowen</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Li</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Yanying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Yingyu</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/436234/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Yonghui</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Shi</surname> <given-names>Qiumei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wu</surname> <given-names>Tonglei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1802612/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Hebei Provincial Key Laboratory of Preventive Veterinary Medicine, Hebei Normal University of Science and Technology</institution>, <addr-line>Qinhuangdao</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Hebei Provincial Center for Livestock Breeding Improvement</institution>, <addr-line>Shijiazhuang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Key Laboratory of Animal Biosafe Risk Prevention and Control (North), Ministry of Agriculture and Rural Affairs, Institute of Animal Science, Chinese Academy of Agricultural Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>College of Animal Medicine, Huazhong Agricultural University</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>The Second Hospital of Qinhuangdao</institution>, <addr-line>Qinhuangdao</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001"><p>Edited by: Lei Deng, Chinese Academy of Agricultural Sciences, China</p></fn>
<fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Yuwen Dong, University of Pennsylvania, United States</p><p>Qiangde Duan, Yangzhou University, China</p><p>Alaa A. Ghazy, National Research Centre (Egypt), Egypt</p><p>Chen Yuan, Hebei Agricultural University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Tonglei Wu, <email>532966952@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1631008</elocation-id>
<history>
<date date-type="received">
<day>19</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Zhang, Chen, Yan, Li, Yang, Chen, Zhang, Chen, Li, Shi and Wu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zhang, Chen, Yan, Li, Yang, Chen, Zhang, Chen, Li, Shi and Wu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Salmonellosis caused by <italic>Salmonella</italic> sp. is a foodborne zoonotic disease that poses a significant threat to public health security. Vaccination is a safe and effective strategy for preventing and controlling <italic>Salmonella</italic> infections. PipC is a chaperone protein associated with <italic>Salmonella</italic> invasion proteins which is crucial for bacteria to invade host cells.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>In this study, a &#x0394;<italic>pipC</italic> mutant strain was generated. Subsequently, we examined the environmental stress tolerance of the mutant strain through <italic>in vitro</italic> simulation experiments. Moreover, its virulence by employing cell and mouse infection models was investigated. Furthermore, we utilized a mouse model to further explore its potential as an attenuated live vaccine against <italic>Salmonella enterica</italic> serovar <italic>Enteritidis</italic> infection.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>The <italic>Salmonella</italic> strain C50336 with a deletion of the <italic>pipC</italic> gene exhibits a significant reduction in its ability to resist environmental stress and virulence. Meanwhile, the expression levels of SPI-1-related genes (<italic>invH</italic>, <italic>sipA</italic>, <italic>sipB</italic>, <italic>sipC</italic>, <italic>sopB</italic>, and <italic>sopE2</italic>) and SPI-2-related genes (<italic>spvB</italic>, <italic>ssrA</italic>, <italic>orf245</italic>, <italic>ssaS</italic>, <italic>ssaT</italic>, <italic>ssaU</italic>, <italic>sseB</italic>, and <italic>sseD</italic>) encoding the <italic>Salmonella</italic> type III secretion system (T3SS) were found to be decreased, leading to a significant reduction in the bacteria&#x2019;s invasion and intracellular survival abilities. The results of the mouse intraperitoneal challenge experiment showed that compared with the wild-type strain, the 50% lethal dose (LD<sub>50</sub>) of the &#x0394;<italic>pipC</italic> strain increased by 47 times, and the bacterial loads in the liver, spleen, and cecum were significantly reduced. When mice were immunized with the &#x0394;<italic>pipC</italic> mutant strain, the immunized mice showed a robust immune response, with significantly increased cytokine and antibody levels in their bodies. Mice vaccinated with the &#x0394;<italic>pipC</italic> mutant strain had 100% immune protection against wild-type <italic>Salmonella</italic> infection.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>This study demonstrates that lack of <italic>pipC</italic> affects <italic>SE</italic> pathogenicity by decreasing its virulence both <italic>in vitro</italic> and <italic>in vivo</italic>. Vaccination of mice with &#x0394;<italic>pipC</italic> conferred development of an acquired immunity and efficacious protection against experimental systemic infection. These results indicated that the &#x0394;<italic>pipC</italic> mutant strain can be used in the development of attenuated live vaccines.</p>
</sec>
</abstract>
<kwd-group>
<kwd><italic>Salmonella enterica</italic> serovar <italic>Enteritidis</italic></kwd>
<kwd>PipC</kwd>
<kwd>virulence</kwd>
<kwd>immune protection</kwd>
<kwd>vaccine</kwd>
</kwd-group>
<contract-num rid="cn1">2023YFD1800701</contract-num>
<contract-num rid="cn2">HBCT2024280205</contract-num>
<contract-num rid="cn2">HBCT2024280406</contract-num>
<contract-sponsor id="cn1">National Key Research and Development Program<named-content content-type="fundref-id">10.13039/501100012166</named-content></contract-sponsor>
<contract-sponsor id="cn2">Hebei Agriculture Research System</contract-sponsor>
<counts>
<fig-count count="9"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="39"/>
<page-count count="15"/>
<word-count count="9123"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Infectious Agents and Disease</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="sec5">
<title>Background</title>
<p><italic>Salmonella</italic> is a facultative intracellular pathogen that belongs to the Gram-negative category and exhibits a remarkable ability to infect a diverse range of animals, including humans. This broad host range not only poses a severe threat to the healthy development of the global aquaculture industry but also undermines public health safety, resulting in substantial economic losses in various aspects (<xref ref-type="bibr" rid="ref8">Ferrari et al., 2019</xref>). Among these, <italic>Salmonella enteritidis</italic> (<italic>SE</italic>) and <italic>Salmonella</italic> Typhimurium are the main serotypes that infect humans, accounting for approximately 40% of human salmonellosis cases (<xref ref-type="bibr" rid="ref3">Cao et al., 2023</xref>). The transmission routes of <italic>SE</italic> to humans are diverse. It can be contracted through the consumption of contaminated food products such as pork, beef, poultry, and eggs. Additionally, in areas with poor sanitation where fecal matter exposure is more likely, the risk of human infection also increases significantly. Once infected, humans may experience a series of symptoms, including abdominal pain, diarrhea, nausea, vomiting, fever, and headaches, which can greatly affect their quality of life and overall health (<xref ref-type="bibr" rid="ref9">Guard-Petter, 2001</xref>).</p>
<p>Antibiotics are commonly used to treat <italic>Salmonella</italic> infections, but their overuse leads to environmental pollution and accelerates the rise of multidrug-resistant strains. This not only reduces treatment effectiveness but also poses a significant threat to public health. In this context, vaccination has emerged as another crucial measure for the prevention and control of <italic>Salmonella</italic> infections, as emphasized by <xref ref-type="bibr" rid="ref26">Ruvalcaba-G&#x00F3;mez et al. (2022)</xref> and <xref ref-type="bibr" rid="ref1">Acevedo-Villanueva et al. (2021)</xref>. Given the facultative intracellular nature of <italic>Salmonella</italic>, strong cellular immunity plays a vital role in clearing the pathogen. As a result, attenuated live vaccines are generally considered to offer more effective immune protection compared to other types of vaccines, as demonstrated by the research of <xref ref-type="bibr" rid="ref18">Lin et al. (2017)</xref> and <xref ref-type="bibr" rid="ref13">Jiang et al. (2022)</xref>. Moreover, previous studies have shown that attenuated live vaccines of <italic>Salmonella</italic> have relatively low virulence to the host. They are capable of inducing a robust and long-lasting mucosal and humoral immune response, as pointed out by <xref ref-type="bibr" rid="ref30">Tennant and Levine (2015)</xref>. This immune response can effectively reduce bacterial adhesion and colonization within the host organism.</p>
<p>Currently, numerous <italic>Salmonella</italic> gene knockout strains have been utilized as live vaccines. For instance, <xref ref-type="bibr" rid="ref38">Zhao et al. (2024)</xref> found in 2024 that immunizing mice with a <italic>Salmonella</italic> strain with the <italic>pal</italic> gene deleted could stimulate good immune protection. <xref ref-type="bibr" rid="ref37">Zhang et al. (2024</xref>, <xref ref-type="bibr" rid="ref35">2025)</xref> found that an attenuated <italic>Salmonella enterica</italic> vaccine with <italic>mcpC</italic> and <italic>cheV</italic> gene knockouts was able to stimulate 100% immune protection in mice. In addition, <xref ref-type="bibr" rid="ref34">Yin et al. (2022)</xref> and <xref ref-type="bibr" rid="ref14">Kamble and Lee (2016)</xref> also demonstrated that attenuated vaccines prepared by deleting virulence genes such as <italic>cpxR</italic>, <italic>lon</italic>, and SPI2 were effective in reducing the colonization of wild-type strains in chickens and provided good immune protection. Overall, the exploration and improvement of <italic>Salmonella</italic> attenuated live vaccines based on gene deletion, are of great significance for safeguarding public health and promoting the sustainable development of the aquaculture industry. <italic>Salmonella</italic> Pathogenicity Island 5 (SPI-5) plays a critical role in the enteropathogenicity of <italic>Salmonella</italic>. It encodes five proteins, namely PipA, PipB, PipC, PipD, and SopB, that are involved in mucosal secretion and inflammatory responses in the intestine. These proteins are regulated by the type III secretion systems (T3SS) encoded by SPI-1 and SPI-2 (<xref ref-type="bibr" rid="ref32">Wang et al., 2020</xref>). Devendra H. Shah et al. reported that <italic>sopB</italic> and <italic>pipB/C</italic> are co-regulated with SPI-1 and promote host cell invasion, suggesting that <italic>pipC</italic> may contribute to the invasive capacity of <italic>Salmonella</italic> (<xref ref-type="bibr" rid="ref4">Darwin et al., 2001</xref>; <xref ref-type="bibr" rid="ref25">Rodr&#x00ED;guez-Escudero et al., 2011</xref>). Previous studies have shown that deletion of SPI-5 reduces the ability of <italic>SE</italic> to colonize the chicken intestine (<xref ref-type="bibr" rid="ref27">Rychlik et al., 2009</xref>; <xref ref-type="bibr" rid="ref29">Shah et al., 2012</xref>). Furthermore, <italic>pipC</italic> has been implicated in the folding of key virulence factors, including the T3SS effector protein SopB. Additionally, literature reports indicate that the expression level of <italic>pipC</italic> is significantly reduced in macrophages compared to bacteria in the early stationary phase (ESP) under <italic>in vitro</italic> conditions, suggesting a potential role of <italic>pipC</italic> in intracellular survival within macrophages. Taken together, these findings indicate that <italic>pipC</italic> may influence the virulence of <italic>SE</italic>, though further experimental validation is required.</p>
<p>To further elucidate the role of <italic>pipC</italic> in <italic>Salmonella</italic> infection and its contribution to immunoprotection, this study aims to construct a <italic>pipC</italic> gene deletion mutant of <italic>SE</italic>. The effects of this gene deletion on bacterial virulence will be evaluated through both <italic>in vitro</italic> and <italic>in vivo</italic> assays, and the immunoprotective efficacy of the deletion strain will be assessed in a mouse model.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<title>Materials and methods</title>
<sec id="sec7">
<title>Bacterial strains, plasmids and cells</title>
<p>The bacterial strains and plasmids used in this study are shown in <xref ref-type="table" rid="tab1">Table 1</xref>. <italic>Salmonella enterica</italic> serovar <italic>Enteritidis</italic> C50336 was the wild-type strain and used for constructing the &#x0394;<italic>pipC</italic> mutant. The &#x0394;<italic>pipC</italic> strain in this study was constructed following the <italic>&#x03BB;</italic>-Red recombinase gene replacement method (<xref ref-type="bibr" rid="ref5">Datsenko and Wanner, 2000</xref>). The primer sequences used for generating and confirming mutant strains are listed in <xref ref-type="table" rid="tab2">Table 2</xref>. All bacterial strains were cultured on Luria-Bertani (LB) agar plates or in LB broth with necessary antibiotics at appropriate concentrations (for example, 100 &#x03BC;g/mL ampicillin and 34 &#x03BC;g/mL chloramphenicol) (<xref ref-type="bibr" rid="ref33">Xiong et al., 2023</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Strains and plasmids used in this study.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Strains or plasmids</th>
<th align="left" valign="top">Characteristics</th>
<th align="left" valign="top">Source</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="3">Strain</td>
</tr>
<tr>
<td align="left" valign="middle">C50336</td>
<td align="left" valign="middle"><italic>Salmonella enterica</italic> serovar <italic>Enteritidis</italic>, wild-type</td>
<td align="left" valign="top" rowspan="4">This study</td>
</tr>
<tr>
<td align="left" valign="middle">&#x0394;<italic>pipC</italic>:<italic>cat</italic></td>
<td align="left" valign="middle">A first recombination strain</td>
</tr>
<tr>
<td align="left" valign="middle">&#x0394;<italic>pipC</italic></td>
<td align="left" valign="middle">A second recombination strain</td>
</tr>
<tr>
<td align="left" valign="middle">&#x0394;<italic>pipC + pipC</italic></td>
<td align="left" valign="middle">&#x0394;<italic>pipC</italic>-complemented strain</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Plasmids</td>
</tr>
<tr>
<td align="left" valign="middle">pKD3</td>
<td align="left" valign="middle">Cm<sup>R</sup>, <italic>cat</italic>, FRT</td>
<td align="left" valign="top" rowspan="4">The Key Laboratory of Preventive Veterinary Medicine, Hebei Province</td>
</tr>
<tr>
<td align="left" valign="middle">pKD46</td>
<td align="left" valign="middle">Amp<sup>R</sup>, encodes lambda red genes (exo, beta, gam), arabinose-inducible promoter for expression (ParaB)</td>
</tr>
<tr>
<td align="left" valign="middle">pCP20</td>
<td align="left" valign="middle">Amp<sup>R</sup> and Cm<sup>R</sup>, encode FLP recombinase</td>
</tr>
<tr>
<td align="left" valign="middle">pBR322</td>
<td align="left" valign="middle">Amp<sup>R</sup> and Tet<sup>R</sup></td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Primers used for the construction of the <italic>pipC</italic> deletion mutant and complemented strain.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
<th align="center" valign="top">Product length (bp)</th>
<th align="left" valign="top">Purpose</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">P1</td>
<td align="left" valign="middle"><underline>TTGGCAGTCAGTAAAAGGCATTTCTTCATTAATCACATCTTGAGTCTTGAGGTAACTAT</underline>tgtgtaggctggagctgcttcg</td>
<td align="center" valign="middle" rowspan="2">1,135</td>
<td align="left" valign="top" rowspan="2">Underline: <italic>pipC</italic> homologous fragment; Lowercase letters: <italic>cat</italic> homologous fragment</td>
</tr>
<tr>
<td align="left" valign="middle">P2</td>
<td align="left" valign="middle"><underline>TTGTAAAGGGCATACGTATCGCGTTTTATCTCATTAAGAAAGTATGTTGACGTATTAAA</underline>catatgaatatcctccttag</td>
</tr>
<tr>
<td align="left" valign="middle">P3</td>
<td align="left" valign="middle">TTATCGCCAGAGGTGCTCAATC</td>
<td align="center" valign="middle" rowspan="2">554 (no recombination)/1,229 (first recombination)/246 (secondary recombination)</td>
<td align="left" valign="middle" rowspan="2">Identification of &#x0394;<italic>pipC</italic></td>
</tr>
<tr>
<td align="left" valign="middle">P4</td>
<td align="left" valign="middle">GCCCCTTACATTTCCACCAAAG</td>
</tr>
<tr>
<td align="left" valign="middle">P5</td>
<td align="left" valign="middle">CG<underline>GGATCC</underline>TTGGCAGTCAGTAAAAGG</td>
<td align="center" valign="middle" rowspan="2">501</td>
<td align="left" valign="top" rowspan="2">Underline: enzyme cleavage site</td>
</tr>
<tr>
<td align="left" valign="middle">P6</td>
<td align="left" valign="middle">GC<underline>GTCGAC</underline>CCACCAAAGATTCTGGTCT</td>
</tr>
<tr>
<td align="left" valign="middle">P7</td>
<td align="left" valign="middle">TCGCTTCGCTACTTGGAG</td>
<td align="center" valign="middle" rowspan="2">593</td>
<td align="left" valign="middle" rowspan="2">Identification of the complemented strain</td>
</tr>
<tr>
<td align="left" valign="middle">P8</td>
<td align="left" valign="middle">AAGGAGCTGACTGGGTTG</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Human epithelial Caco-2 BBE cells and mouse macrophage RAW264.7 cells used in this study were provided by BeNa Culture Collection (Shanghai, China). Both cell types were cultured in DMEM (Thermo Fisher Scientific Co., Ltd.) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific Co., Ltd.). Antibiotics were added as necessary, such as 50&#x202F;&#x03BC;g/mL streptomycin and 50&#x202F;U/mL penicillin, or 50&#x202F;&#x03BC;g/mL gentamicin, in an incubator with 5% CO&#x2082;.</p>
</sec>
<sec id="sec8">
<title>Experimental animals and ethical statement</title>
<p>Kunming (KM) mice were obtained from Beijing Speifu Biotechnology Co., Ltd. Throughout the experiment, the mice were maintained in a sterile environment under standard housing conditions with an ambient temperature consistently kept at 22.0&#x202F;&#x00B1;&#x202F;0.5&#x00B0;C and relative humidity maintained at 60&#x202F;&#x00B1;&#x202F;10%. A 12-h light/dark cycle was established for the housing conditions. All animal experiments were conducted in full compliance with international ethical standards and the Experimental Animal Regulation Ordinances (HPDST 2020-17) stipulated by the Hebei Provincial Department of Science and Technology. The study protocol was reviewed and approved by the Animal Care and Use Committee of Hebei Normal University of Science and Technology.</p>
</sec>
<sec id="sec9">
<title>Construction of <italic>pipC</italic> gene deletion and complementation strains of <italic>SE</italic></title>
<p>The <italic>pipC</italic> gene deletion strain in this study was constructed using the <italic>&#x03BB;</italic> homologous recombination method (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Briefly, the auxiliary plasmid pKD46 was introduced into C50336 through electroporation, which encodes the Gam, Exo, and Beta proteins required for &#x03BB; homologous recombination. Using pKD3 as a template, the knockout fragments were amplified by P1 and P2. The knockout fragment was then introduced into C50336 containing pKD46 via electroporation, resulting in a primary recombinant strain with chloramphenicol resistance. This strain was selected using LB agar plates containing chloramphenicol and verified using primers P3 and P4. The positive strain obtained was named &#x0394;<italic>pipC</italic>:<italic>cat</italic>. The pCP20 plasmid, which encodes the Flp recombinase, was able to excise the <italic>cat</italic> gene from the knockout fragment. The pCP20 plasmid was introduced into &#x0394;<italic>pipC</italic>:<italic>cat</italic> by electroporation, resulting in a secondary recombinant strain. This strain was verified using primers P3 and P4. The positive strain obtained was named &#x0394;<italic>pipC</italic>.</p>
<p>To construct the complement strain, the nucleic acids of C50336 were used as a template, and the complement fragment was amplified using P5 and P6. The complement fragment and pBR322 vector plasmid were digested with restriction endonucleases <italic>BamH I</italic> and <italic>Sal I</italic>, respectively. The two digested fragments were ligated using T4 DNA ligase. The recombinant vector was introduced into &#x0394;<italic>pipC</italic> by electroporation and verified with P7 and P8. The positive strain was named &#x0394;<italic>pipC</italic> + <italic>pipC</italic>.</p>
</sec>
<sec id="sec10">
<title>Genetic stability testing</title>
<p>To determine the genetic stability of the &#x0394;<italic>pipC</italic>, it was serially passaged 40 times in LB medium, every 12&#x202F;h. Nucleic acids from liquid cultures are extracted every other generation and PCR verification using P3 and P4.</p>
</sec>
<sec id="sec11">
<title>Growth characteristics assay</title>
<p>The overnight cultures of C50336, &#x0394;<italic>pipC</italic>, and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were subcultured at a 1:100 ratio into 5&#x202F;mL of LB liquid medium and incubated at 37&#x00B0;C in a shaking incubator. Growth was determined by monitoring the absorbance of bacterial cultures at 600&#x202F;nm (OD<sub>600</sub> values). Growth curves were plotted based on the growth of each strain at different time points.</p>
</sec>
<sec id="sec12">
<title><italic>In vitro</italic> stress simulation experiments</title>
<p>Overnight cultures of C50336, &#x0394;<italic>pipC</italic>, and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were washed three times with PBS and resuspended in the original volume. The bacterial counts before stress were determined using the traditional plate count method. The bacterial suspensions were exposed to acid stress (pH 3.5), alkaline stress (pH 10.0), and heat stress (42&#x00B0;C) for 1&#x202F;h, as well as to oxidative stress (10&#x202F;mmol/L H<sub>2</sub>O<sub>2</sub>) for 30&#x202F;min. After stress exposure, the bacterial counts were determined. The survival rate of each strain under different conditions was calculated as follows: survival rate&#x202F;=&#x202F;(post-stress bacterial count)/(initial bacterial count).</p>
</sec>
<sec id="sec13">
<title>Cell culture</title>
<p>The human epithelial cancer cell lines Caco-2 were cultured in Dulbecco&#x2019;s modified Eagle medium (DMEM) supplemented with 20% fetal bovine serum (FBS) and 1% penicillin-streptomycin solution. The mouse macrophage RAW264.7 was cultured in DMEM containing 10% FBS and 1% penicillin-streptomycin solution. When the cells reached 80% confluence, the monolayers were washed three times with PBS. The cells were then seeded in 12-well tissue culture plates at a density of 1&#x202F;&#x00D7;&#x202F;10<sup>6</sup> cells/well. The plates were incubated at 37&#x00B0;C in an atmosphere containing 5% CO<sub>2</sub>.</p>
</sec>
<sec id="sec14">
<title>Adherence and invasion assays</title>
<p>To investigate the impact of <italic>pipC</italic> gene deletion on the adhesion and invasion ability of <italic>SE</italic>, the overnight cultures of C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were washed three times with PBS and subsequently resuspended. The number of bacteria per mL of bacterial suspension (number of infected bacteria) was measured. Following the washing of confluent cell monolayers with DMEM, C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were inoculated, respectively, onto the Caco-2 cells at a multiplicity of infection (MOI) of 100:1 and were incubated for 1&#x202F;h at 37&#x00B0;C under 5% CO<sub>2</sub> (<xref ref-type="bibr" rid="ref33">Xiong et al., 2023</xref>).</p>
</sec>
<sec id="sec15">
<title>Adhesion assay</title>
<p>For bacterial adhesion, the cells were washed, and then incubated with PBS containing Triton X-100 (0.5%) at 37&#x00B0;C for 10&#x202F;min. The cell lysates were serially diluted and inoculated onto LB agar for counting. The number of bacteria per mL of cell lysate (number of adherent bacteria) was measured. The adhesion rate was calculated using the formula: Adhesion rate&#x202F;=&#x202F;(number of adherent bacteria/number of infected bacteria)&#x202F;&#x00D7;&#x202F;100%.</p>
</sec>
<sec id="sec16">
<title>Invasion assay</title>
<p>For bacterial invasion, 1&#x202F;h after bacterial colonization, the cells were incubated for an additional 1&#x202F;h in DMEM with gentamicin (100&#x202F;&#x03BC;g/mL), washed and incubated with PBS containing Triton X-100 (0.5%) at 37&#x00B0;C for 10&#x202F;min. The cell lysates were serially diluted and inoculated onto LB agar for counting. The number of bacteria per mL of cell lysate (number of invading bacteria) was measured. Invasion rate&#x202F;=&#x202F;(number of invading bacteria/number of infected bacteria)&#x202F;&#x00D7;&#x202F;100%.</p>
</sec>
<sec id="sec17">
<title>Intracellular proliferation assay</title>
<p>To evaluate the survival rate of &#x0394;<italic>pipC</italic> in phagocytic cells, after infecting the cells with bacteria for 2&#x202F;h as described above, DMEM containing 100&#x202F;&#x03BC;g/mL gentamicin was added and incubated for 1&#x202F;h. One group of cells was then washed and lysed with 0.5% Triton X-100, and the intracellular bacteria were counted (intracellular bacteria at 3&#x202F;h). Another group of cells was washed and incubated with DMEM containing 10&#x202F;&#x03BC;g/mL gentamicin at 37&#x00B0;C for 20&#x202F;h. These cells were also lysed with 0.5% Triton X-100, and the intracellular bacteria were counted (intracellular bacteria at 23&#x202F;h). Intracellular survival rate&#x202F;=&#x202F;(intracellular bacteria at 23&#x202F;h/intracellular bacteria at 3&#x202F;h)&#x202F;&#x00D7;&#x202F;100%.</p>
</sec>
<sec id="sec18">
<title>Assessment of bacterial virulence</title>
<p>A total of 75 six-week-old KM mice were randomly divided into 15 groups (<italic>n</italic>&#x202F;=&#x202F;5). These groups were categorized into three sets: five groups for the &#x0394;<italic>pipC</italic>, five groups for the C50336, and the remaining five groups designated as the &#x0394;<italic>pipC</italic> + <italic>pipC</italic> group. Mice in the &#x0394;<italic>pipC</italic> groups were intraperitoneally (i.p.) inoculated with &#x0394;<italic>pipC</italic> containing of 1.68&#x202F;&#x00D7;&#x202F;10<sup>9</sup>, 1.68&#x202F;&#x00D7;&#x202F;10<sup>8</sup>, 1.68&#x202F;&#x00D7;&#x202F;10<sup>7</sup>, 1.68&#x202F;&#x00D7;&#x202F;10<sup>6</sup> or 1.68&#x202F;&#x00D7;&#x202F;10<sup>5</sup>&#x202F;CFU/mouse, respectively. Similarly, the C50336 groups were i.p. inoculated with C50336 containing of 2&#x202F;&#x00D7;&#x202F;10<sup>7</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>6</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>5</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>4</sup> or 2&#x202F;&#x00D7;&#x202F;10<sup>3</sup>&#x202F;CFU/mouse, respectivly. The &#x0394;<italic>pipC</italic> + <italic>pipC</italic> groups were i.p. inoculated with &#x0394;<italic>pipC</italic> + <italic>pipC</italic> containing of 2&#x202F;&#x00D7;&#x202F;10<sup>7</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>6</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>5</sup>, 2&#x202F;&#x00D7;&#x202F;10<sup>4</sup> or 2&#x202F;&#x00D7;&#x202F;10<sup>3</sup>&#x202F;CFU/mouse, respectively. Five additional mice were i.p. injected with the same volume of PBS as a negative control.</p>
<p>The number of dead mice was recorded for 14&#x202F;days and LD<sub>50</sub> was calculated, which was calculated using the formula of log<sub>10</sub> [50% endpoint]&#x202F;=&#x202F;A&#x202F;+&#x202F;(B&#x202F;&#x00D7;&#x202F;C), where A&#x202F;=&#x202F;log<sub>10</sub> [infectious dose showing a mortality next below 50%], B&#x202F;=&#x202F;difference of logarithms&#x202F;=&#x202F;[50% &#x2212; (mortality at infectious dose next below 50%)]/[(mortality next above 50%) &#x2212; (mortality next below 50%)], and C&#x202F;=&#x202F;log<sub>10</sub> [difference between serial infectious doses used in challenge studies] (<xref ref-type="bibr" rid="ref22">Park et al., 2022</xref>; <xref ref-type="bibr" rid="ref36">Zhang et al., 2019</xref>).</p>
</sec>
<sec id="sec19">
<title>RNA extraction and qPCR</title>
<p>In order to further investigate the effect of <italic>pipC</italic> gene deletion on the virulence of <italic>SE</italic>, qPCR was used to measure the expression levels of virulence genes in C50336, &#x0394;<italic>pipC</italic>, and &#x0394;<italic>pipC</italic> + <italic>pipC</italic>. In short, the bacteria were cultured to the logarithmic phase and total RNA was extracted using an RNA extraction kit (Aidlab, Beijing, China). Complementary DNA (cDNA) was synthesized using a reverse transcription kit (TOYOBO, Osaka, Japan). Primers were designed by referring to previous literature (<xref ref-type="bibr" rid="ref31">Upadhyaya et al., 2013</xref>). The primer sequences used for qPCR are listed in <xref ref-type="table" rid="tab3">Table 3</xref>. Using cDNA as a template, the relative gene expression was quantified using the comparative critical threshold (Ct) method through qPCR. Data were normalized to the endogenous control (<italic>16S rRNA</italic>), and the level of candidate gene expression between treated and control samples were determined. The qPCR thermal cycling conditions were as follows: initial denaturation at 95&#x00B0;C for 10&#x202F;min, followed by 40 cycles of 95&#x00B0;C for 15&#x202F;s and 60&#x00B0;C for 1&#x202F;min.</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>The qPCR primers of virulence genes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle"><italic>16S-</italic>F</td>
<td align="left" valign="middle">CCAGGGCTACACACGTGCTA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>16S-</italic>R</td>
<td align="left" valign="middle">TCTCGCGAGGTCGCTTCT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>invH-</italic>F</td>
<td align="left" valign="middle">CCCTTCCTCCGTGAGCAAA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>invH-</italic>R</td>
<td align="left" valign="middle">TGGCCAGTTGCTCTTTCTGA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>orf245-</italic>F</td>
<td align="left" valign="middle">CAGGGTAATATCGATGTGGACTACA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>orf245-</italic>R</td>
<td align="left" valign="middle">GCGGTATGTGGAAAACGAGTTT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipA-</italic>F</td>
<td align="left" valign="middle">CAGGGAACGGTGTGGAGGTA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipA-</italic>R</td>
<td align="left" valign="middle">AGACGTTTTTGGGTGTGATACGT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipB-</italic>F</td>
<td align="left" valign="middle">GCCACTGCTGAATCTGATCCA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipB-</italic>R</td>
<td align="left" valign="middle">CGAGGCGCTTGCTGATTT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssrA-</italic>F</td>
<td align="left" valign="middle">CGAGTATGGCTGGATCAAAACA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssrA-</italic>R</td>
<td align="left" valign="middle">TGTACGTATTTTTTGCGGGATGT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>spvB-</italic>F</td>
<td align="left" valign="middle">TGGGTGGGCAACAGCAA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>spvB-</italic>R</td>
<td align="left" valign="middle">GCAGGATGCCGTTACTGTCA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaS</italic>-F</td>
<td align="left" valign="middle">CGCAACTTTTATGGATCGTC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaS</italic>-R</td>
<td align="left" valign="middle">TGTAGCGTTTGGTCCTGTATT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipC</italic>-F</td>
<td align="left" valign="middle">TCTGGCAAATAATGTCACGA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sipC</italic>-R</td>
<td align="left" valign="middle">CGCTCTGGGAAATACTACCG</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sopB</italic>-F</td>
<td align="left" valign="middle">ACCCGCCTGGAATTGTAA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sopB</italic>-R</td>
<td align="left" valign="middle">GAAAGATTGAGCACCTCTGG</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaT</italic>-F</td>
<td align="left" valign="middle">TGCTTATGTCACTTACCTTTCC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaT</italic>-R</td>
<td align="left" valign="middle">AATATCGTACCCATTGTCGC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaU</italic>-F</td>
<td align="left" valign="middle">TATTGCGGTTTGTCTTGGC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>ssaU</italic>-R</td>
<td align="left" valign="middle">GGGATGCAGTTGCGTTCA</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sseB</italic>-F</td>
<td align="left" valign="middle">CTTATCCCAGCAAAATCCG</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sseB</italic>-R</td>
<td align="left" valign="middle">TTAGCAATCACCTCATCCATCT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sseD</italic>-F</td>
<td align="left" valign="middle">CTTCTTCCACTCCATCTCCC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sseD</italic>-R</td>
<td align="left" valign="middle">CGTCTGTAAAACATTGACTTGC</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sopE2</italic>-F</td>
<td align="left" valign="middle">TAACACTATCCACCCAGCACT</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>sopE2</italic>-R</td>
<td align="left" valign="middle">TTAATACCGCCCTACCCTC</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec20">
<title>Bacterial colonization assay</title>
<p>Thirty mice were randomly divided into two groups (<italic>n</italic>&#x202F;=&#x202F;15). One group was intraperitoneally injected with 1&#x202F;&#x00D7;&#x202F;10<sup>4</sup>&#x202F;CFU/mouse of &#x0394;<italic>pipC</italic>, while the other group received an equal dose of C50336. Additionally, three mice were injected with 200&#x202F;&#x03BC;L of PBS as a negative control. At predetermined time points (3&#x202F;days, 7&#x202F;days, and 14&#x202F;days), five mice from each group were randomly selected and euthanized. Their spleens, livers, and cecums were collected, homogenized in PBS, and subsequently serially diluted before being evenly spread on XLT4 agar. The number of CFUs for each sample was determined 12&#x202F;h later. For this animal study, all mice were anesthetized using a 20% urethane (ethyl carbamate) solution, and every effort was made to ensure humane treatment of the animals.</p>
</sec>
<sec id="sec21">
<title>Vaccination schedules of oral attenuated live vaccine and sample collection</title>
<p>Twenty-four female KM mice, aged 8&#x202F;weeks, were randomly divided into two groups (<italic>n</italic>&#x202F;=&#x202F;12): an immunization group and a control group. On day 0, the immunization group received an oral administration of 1&#x202F;&#x00D7;&#x202F;10<sup>6</sup>&#x202F;CFU of &#x0394;<italic>pipC</italic>, whereas the control group was orally administered 200&#x202F;&#x03BC;L of PBS. A booster immunization with an identical dose was given to the immunization group on day 14 dpi, while the control group received an equivalent volume of PBS.</p>
<p>At 14 dpi and 28 dpi, 6 mice from each group were randomly euthanized, and spleens were collected for splenic lymphocyte stimulation test and detection of cytokine expression levels. Additionally, serum and feces were collected from 3 mice for IgG and SIgA detection. The vaccination regimen of this study is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>The vaccination scheme and detection protocol designed in this study.</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g001.tif"/>
</fig>
</sec>
<sec id="sec22">
<title><italic>Salmonella</italic> soluble antigen preparation</title>
<p>C50336 was cultivated overnight at 37&#x00B0;C, 180&#x202F;rpm with shaking until it reached the logarithmic phase. The bacteria were centrifuged at a speed of 13,000&#x202F;&#x00D7;&#x202F;g at 4&#x00B0;C, washed three times with PBS, and resuspended in PBS to a concentration of 1&#x202F;&#x00D7;&#x202F;10<sup>10</sup>&#x202F;CFU/mL. Use SCIENTZ ultrasonic homogenizer (SCIENTZ-IID, Ningbo, China) to sonicate the cells and centrifuge the 13,000&#x202F;&#x00D7;&#x202F;g sample at 4&#x00B0;C to granulate the fragments. The sample was sterilized through a 0.22&#x202F;&#x03BC;m PES (polyethersulfone) filter (Merck, Darmstadt, Germany) (<xref ref-type="bibr" rid="ref12">Ji et al., 2022</xref>).</p>
</sec>
<sec id="sec23">
<title>Splenic lymphocytes stimulation test</title>
<p>Lymphocytes were isolated from each group of three spleen samples at 14 and 28 dpi. After Trypan blue dye exclusion testing, suspensions of splenic mononuclear cells (1&#x202F;&#x00D7;&#x202F;10<sup>7</sup> cells/well) were cultured in Roswell Park Memorial Institute 1,640 medium (RPMI-1640) supplemented with 10% FBS and 100&#x202F;&#x03BC;g/mL penicillin-streptomycin within 96-well tissue culture plates. These cultures were then incubated with 10&#x202F;&#x03BC;g/mL soluble antigen or without any stimulant as a negative control, under conditions of 37&#x00B0;C and 5% CO&#x2082; for a duration of 72&#x202F;h. Lymphocyte proliferation was measured using an MTT kit (Beyotime, Shanghai, China). The cell proliferation was expressed as the stimulation index (SI), which was calculated using the equation: SI&#x202F;=&#x202F;(OD<sub>570</sub> of the antigen-stimulated cells)/(OD<sub>570</sub> of the unstimulated cells) (<xref ref-type="bibr" rid="ref15">Kang et al., 2021</xref>).</p>
</sec>
<sec id="sec24">
<title>The expression of cytokines in the spleen</title>
<p>Quantitative real-time PCR (qPCR) was employed to assess the mRNA expression levels of splenic cytokines, including IL-1&#x03B2;, IL-2, IL-4, IL-6, IL-10, TNF-&#x03B1;, and IFN-&#x03B3;, at 14 and 28&#x202F;days post-immunization (dpi). Total RNA was extracted from spleen tissues using Triquick Reagent (Solarbio, Beijing, China), and first-strand cDNA was synthesized with a cDNA synthesis kit (TOYOBO, Osaka, Japan). Samples were stored at &#x2212;80&#x00B0;C until further use. qPCR was performed using the Ultra SYBR Green Mixture (CWBio, Jiangsu, China) on a Lepgen-96 Real-Time PCR System (LEpu, Lepgen-96, China). The primer sequences used for qPCR are listed in <xref ref-type="table" rid="tab4">Table 4</xref>. Cytokine expression levels were normalized to the internal reference genes gapdh and &#x03B2;-actin, and relative expression was calculated using the 2<sup>&#x2212;&#x0394;&#x0394;Ct</sup> method (<xref ref-type="bibr" rid="ref15">Kang et al., 2021</xref>). The thermal cycling conditions were as follows: initial denaturation at 95&#x00B0;C for 10&#x202F;min, followed by 40&#x202F;cycles of denaturation at 95&#x00B0;C for 15&#x202F;s and annealing/extension at 60&#x00B0;C for 1&#x202F;min.</p>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>The qPCR primers of cytokines.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Primers</th>
<th align="left" valign="top">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">gapdh-F</td>
<td align="left" valign="middle">AGGTCGGTGTGAACGGATTTG</td>
</tr>
<tr>
<td align="left" valign="middle">gapdh-R</td>
<td align="left" valign="middle">TGTAGACCATGTAGTTGAGGTCA</td>
</tr>
<tr>
<td align="left" valign="middle">&#x03B2;-actin-F</td>
<td align="left" valign="middle">TTCAACACCCCAGCCATG</td>
</tr>
<tr>
<td align="left" valign="middle">&#x03B2;-actin-R</td>
<td align="left" valign="middle">CCTCGTAGATGGGCACAGT</td>
</tr>
<tr>
<td align="left" valign="middle">IL-1&#x03B2;-F</td>
<td align="left" valign="middle">GACTGTTTCTAATGCCTTCCC</td>
</tr>
<tr>
<td align="left" valign="middle">IL-1&#x03B2;-R</td>
<td align="left" valign="middle">ATGGTTTCTTGTGACCCTGA</td>
</tr>
<tr>
<td align="left" valign="middle">IL-2-F</td>
<td align="left" valign="middle">TGAGCAGGATGGAGAATTACAGG</td>
</tr>
<tr>
<td align="left" valign="middle">IL-2-R</td>
<td align="left" valign="middle">GTCCAAGTTCATCTTCTAGGCAC</td>
</tr>
<tr>
<td align="left" valign="middle">IL-4-F</td>
<td align="left" valign="middle">GGTCTCAACCCCCAGCTAGT</td>
</tr>
<tr>
<td align="left" valign="middle">IL-4-R</td>
<td align="left" valign="middle">GCCGATGATCTCTCTCAAGTGAT</td>
</tr>
<tr>
<td align="left" valign="middle">IL-6-F</td>
<td align="left" valign="middle">TAGTCCTTCCTACCCCAATTTCC</td>
</tr>
<tr>
<td align="left" valign="middle">IL-6-R</td>
<td align="left" valign="middle">TTGGTCCTTAGCCACTCCTTC</td>
</tr>
<tr>
<td align="left" valign="middle">IL-10-F</td>
<td align="left" valign="middle">CTTACTGACTGGCATGAGGATCA</td>
</tr>
<tr>
<td align="left" valign="middle">IL-10-R</td>
<td align="left" valign="middle">GCAGCTCTAGGAGCATGTGG</td>
</tr>
<tr>
<td align="left" valign="middle">IFN-&#x03B3;-F</td>
<td align="left" valign="middle">ATGAACGCTACACACTGCATC</td>
</tr>
<tr>
<td align="left" valign="middle">IFN-&#x03B3;-R</td>
<td align="left" valign="middle">CCATCCTTTTGCCAGTTCCTC</td>
</tr>
<tr>
<td align="left" valign="middle">TNF-&#x03B1;-F</td>
<td align="left" valign="middle">CCCTCACACTCAGATCATCTTCT</td>
</tr>
<tr>
<td align="left" valign="middle">TNF-&#x03B1;-R</td>
<td align="left" valign="middle">GCTACGACGTGGGCTACAG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec25">
<title>Detection of IgG and SIgA</title>
<p>To examine the antibody responses, serum and feces samples were collected from 3 mice per group at 14 and 28 dpi after inoculation with the initial and booster doses of &#x0394;<italic>pipC</italic>. Enzyme-linked immunosorbent assay (ELISA) was employed to quantify the serum IgG and fecal IgA (SIgA) responses against the soluble antigen derived from <italic>SE</italic>. For serum extraction, whole blood samples were centrifuged for 10&#x202F;min at 10,000&#x202F;&#x00D7;&#x202F;g at 4&#x00B0;C. The resultant supernatant, containing the serum, was carefully separated from the pellet and preserved at &#x2212;20&#x00B0;C until use. To obtain the fecal supernatant, the feces samples were weighed, followed by the addition of a 25% weight/volume (w/v) solution of fecal slurry comprised of 0.01% sodium azide, 1% protease inhibitor in PBS. The samples were homogenized by vortexing for 15&#x202F;min. After centrifugation, collect the supernatant and store it at &#x2212;80&#x00B0; C for IgA detection.</p>
<p>The ELISA plates were coated with <italic>Salmonella</italic> soluble antigen (1&#x202F;&#x03BC;g/well) and incubated overnight at 4&#x00B0;C. Wells were blocked with 5% skim milk at 37&#x00B0;C for 2&#x202F;h (200&#x202F;&#x03BC;L/well), followed by washing three times with PBS containing 0.05% Tween-20 (PBST) (280&#x202F;&#x03BC;L/well). Dilute the serum sample at 1:200 and add it to the well, then incubate at 4&#x00B0;C for 1&#x202F;h (100&#x202F;&#x03BC;L/well), and wash three times with PBST. The secondary Ab goat anti-mouse IgG-HRP diluted 1:10,000 was added (100&#x202F;&#x03BC;L/well) (Applygen, Beijing, China). The Ab was allowed to interact with the samples for 35&#x202F;min at 37&#x00B0;C, followed by washing three times with PBST. Add 3,3&#x2032;,5,5&#x2032;-tetramethylbenzidine (TMB) substrate (100&#x202F;&#x03BC;L/well) and incubate at 37&#x00B0;C for 10&#x202F;min. The reaction was terminated by adding 50&#x202F;&#x03BC;L of 2&#x202F;M H<sub>2</sub>SO<sub>4</sub> to each well, and the absorbance was read at 450&#x202F;nm in plate reader (Tecan, Shanghai, China).</p>
<p>For IgA, the ELISA plates were coated with 1&#x202F;&#x03BC;g <italic>Salmonella</italic> soluble antigen per well and incubated overnight. Wells were blocked with 5% skim milk at 37&#x00B0;C for 2&#x202F;h, followed by washing three times with PBST. The undiluted fecal supernatant was added to the well (100&#x202F;&#x03BC;L/well), followed by incubated at 4&#x00B0;C for 1&#x202F;h. The secondary Ab goat anti-mouse IgA-HRP diluted 1:10,000 was added, and the rest of the protocol was performed as described above (<xref ref-type="bibr" rid="ref7">Emerson et al., 2022</xref>).</p>
</sec>
<sec id="sec26">
<title>Immune protection assessment for the &#x0394;<italic>pipC</italic></title>
<p>To evaluate the immune protection of &#x0394;<italic>pipC</italic>. Twenty 6-week-old female KM mice were randomly divided into 2 groups (<italic>n</italic>&#x202F;=&#x202F;10), namely the vaccinated group and the unvaccinated group. The vaccinated group was orally immunized with 1&#x202F;&#x00D7;&#x202F;10<sup>6</sup>&#x202F;CFU/mouse of &#x0394;<italic>pipC</italic>, while the unvaccinated group was orally immunized with 200&#x202F;&#x03BC;L of PBS. In addition, another 10 mice without vaccination and challenge were used as the control group. At 14 dpi, the vaccinated mice received the same dose of &#x0394;<italic>pipC</italic> for enhanced immunity. At 28 dpi, the vaccinated group and unvaccinated group were challenged with 2&#x202F;&#x00D7;&#x202F;10<sup>7</sup>&#x202F;CFU/mouse of C50336 by intraperitoneal injections. Deaths and clinical symptoms were recorded daily for 14 d post the challenge (dpc), and calculate the relative survival rate according to the formula: Relative survival rate&#x202F;=&#x202F;(mortality rate of the unvaccinated group &#x2212; mortality rate of the vaccinated group)/mortality rate of the unvaccinated group &#x00D7; 100%.</p>
</sec>
<sec id="sec27">
<title>Statistical analysis</title>
<p>Statistical analysis was conducted using GraphPad Prism 9 (GraphPad Software, CA, United States) and IBM SPSS (IBM Corporation, Armonk, NY, United States) software. Data are expressed as the mean &#x00B1; standard error of the mean (SEM). All statistical analysis were two-way ANOVA and post-test. Differences between two samples were evaluated using Student&#x2019;s <italic>t</italic>-test. Significant differences are indicated with an asterisk (&#x002A;), where &#x002A;: <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, &#x002A;&#x002A;: 0.001&#x202F;&#x003C;&#x202F;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, and &#x002A;&#x002A;&#x002A;: <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001 are considered to represent statistically significant differences in mean values. ns means not significant (<xref ref-type="bibr" rid="ref16">Kirthika et al., 2020</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="sec28">
<title>Results</title>
<sec id="sec29">
<title>The <italic>&#x0394;pipC</italic> and complementation strain were successfully constructed</title>
<p>We constructed a <italic>pipC</italic> gene deletion strain of <italic>SE</italic> by using the <italic>&#x03BB;</italic>-Red homologous recombination method and constructed a complementation strain by using the pBR322 plasmid. The primers P3 and P4, P7 and P8 were used to identify &#x0394;<italic>pipC</italic> and &#x0394; <italic>pipC</italic> + <italic>pipC</italic>, respectively. As shown in <xref ref-type="fig" rid="fig2">Figures 2A</xref>,<xref ref-type="fig" rid="fig2">B</xref>, the <italic>pipC</italic> gene deletion strain and complementation strain have been successfully constructed.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p><bold>(A)</bold> PCR identification of &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic>:<italic>cat</italic> mutants. The wild-type strain C50336 yields a 554&#x202F;bp amplicon corresponding to the intact <italic>pipC</italic> gene. In contrast, the &#x0394;<italic>pipC</italic> mutant produces a 246&#x202F;bp fragment, while the &#x0394;<italic>pipC</italic>:<italic>cat</italic> strain generates a 1,229&#x202F;bp product. <bold>(B)</bold> PCR confirmation of the &#x0394;<italic>pipC</italic> complemented strain. The &#x0394;<italic>pipC</italic> + <italic>pipC</italic> strain yields a 594&#x202F;bp PCR product, indicating successful complementation. <bold>(C)</bold> Assessment of &#x0394;<italic>pipC</italic> genetic stability. Lanes 1&#x2013;20 show 246&#x202F;bp PCR products from sequential passages of the &#x0394;<italic>pipC</italic> mutant, and lane 21 displays a 554&#x202F;bp band from the wild-type C50336 strain.</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g002.tif"/>
</fig>
</sec>
<sec id="sec30">
<title>&#x0394;<italic>pipC</italic> has good genetic stability</title>
<p>The &#x0394;<italic>pipC</italic> mutant was serially passaged 40 times in LB medium, and the presence of the <italic>pipC</italic> deletion was then assessed by PCR (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The <italic>pipC</italic> deletion was still detectable in the &#x0394;<italic>pipC</italic> mutant strain, indicating that this strain has good genetic stability.</p>
</sec>
<sec id="sec31">
<title>The <italic>pipC</italic> gene does not affect the growth ability of <italic>SE</italic></title>
<p>As shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref>, the growth characteristics of C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> in LB medium did not differ greatly. This indicated that <italic>pipC</italic> deletion did not influence the growth characteristics of <italic>SE</italic>.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p><bold>(A)</bold> Growth curves for the C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic>. All strains were cultured in LB medium. <bold>(B)</bold> Survival rate of &#x0394;<italic>pipC</italic> under different environmental stress. Data are presented as the mean &#x00B1; SD of three independent replicates. Statistical significance was determined as <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01 (&#x002A;&#x002A;) and <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001 (&#x002A;&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g003.tif"/>
</fig>
</sec>
<sec id="sec32">
<title>The deletion of <italic>pipC</italic> gene weakens the resistance of <italic>SE</italic> to environmental stress</title>
<p>To investigate whether the deletion of the <italic>pipC</italic> gene affects the resistance of <italic>SE</italic> to environmental stress, the survival rates of C50336, &#x0394;<italic>pipC</italic>, and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were compared under acid stress (pH 3.5), alkaline stress (pH 10.0), oxidative stress (H<sub>2</sub>O<sub>2</sub>), and heat stress (42&#x00B0;C). The results shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref> reveal that, compared to C50336, the survival rate of &#x0394;<italic>pipC</italic> was significantly reduced under acidic, alkaline, and oxidative stress conditions, whereas no statistically significant difference was observed under heat stress conditions. Since <italic>pipC</italic> deletion did not affect the growth characteristics of <italic>SE</italic>, the reduced survival rate of the mutant strain can be attributed to the role of the <italic>pipC</italic> gene in enhancing resistance to acid, alkaline, and oxidative stress.</p>
</sec>
<sec id="sec33">
<title>The &#x0394;<italic>pipC</italic> mutant shows attenuated virulence <italic>in vitro</italic></title>
<p>The adhesion rate and invasion rate in human epithelial Caco-2, and the intracellular survival rate in mouse macrophage RAW264.7 of &#x0394;<italic>pipC</italic> and C50336 was determined. As shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, the adhesion rate of bacteria was not different between C50336 and &#x0394;<italic>pipC</italic> in Caco-2. However, the invasion rate in Caco-2 and the intracellular survival rate in RAW264.7 of &#x0394;<italic>pipC</italic>, compared to of C50336, showed significantly reduced (<xref ref-type="fig" rid="fig4">Figures 4B</xref>,<xref ref-type="fig" rid="fig4">C</xref>). These results indicate that <italic>SE</italic> with <italic>pipC</italic> deletion shows attenuated virulence <italic>in vitro</italic>.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p><bold>(A)</bold> Adherence and <bold>(B)</bold> invasion assays for C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> to Caco-2. The invasion rate of C50336 is considered to be 100%, and the invasiveness of &#x0394;<italic>pipC</italic> or &#x0394;<italic>pipC</italic> + <italic>pipC</italic> is calculated as its percentage. <bold>(C)</bold> Intracellular survival assay for C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> to RAW264.7. Data are presented as the mean &#x00B1; SD of three independent replicates. Statistical significance was determined as <italic>p</italic> &#x003C; 0.05 (&#x002A;) and <italic>p</italic> &#x003C; 0.01 (&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g004.tif"/>
</fig>
</sec>
<sec id="sec34">
<title>The &#x0394;<italic>pipC</italic> exhibits reduced virulence in a mouse model</title>
<p>The virulence of the &#x0394;<italic>pipC</italic> and C50336 strains was evaluated in 6-week-old KM mouse after i.p. challenge. As shown in <xref ref-type="table" rid="tab5">Table 5</xref>, the LD<sub>50</sub> of &#x0394;<italic>pipC</italic> was 2.99&#x202F;&#x00D7;&#x202F;10<sup>7</sup>&#x202F;CFU, which was 47-fold higher than that of the wild-type C50336 (2.99&#x202F;&#x00D7;&#x202F;10<sup>7</sup>/6.32&#x202F;&#x00D7;&#x202F;10<sup>5</sup>&#x202F;&#x2248;&#x202F;47). The LD<sub>50</sub> of &#x0394;<italic>pipC</italic>+<italic>pipC</italic> is 1&#x202F;&#x00D7;&#x202F;10<sup>6</sup>&#x202F;CFU/mouse. The result indicated that the virulence of the &#x0394;<italic>pipC</italic> was attenuated compared to the C50336.</p>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>The LD<sub>50</sub> of the C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC + pipC</italic> in mice.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Group</th>
<th align="center" valign="top">Dose (CFU/mouse)</th>
<th align="center" valign="top">Number of deaths/Total number of mice</th>
<th align="center" valign="top">LD<sub>50</sub> (CFU)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="5">C50336</td>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>7</sup></td>
<td align="center" valign="top">5/5</td>
<td align="center" valign="top" rowspan="5">6.32&#x202F;&#x00D7;&#x202F;10<sup>5</sup></td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>6</sup></td>
<td align="center" valign="top">3/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>5</sup></td>
<td align="center" valign="top">2/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>4</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>3</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="5">&#x0394;<italic>pipC</italic></td>
<td align="center" valign="top">1.68&#x202F;&#x00D7;&#x202F;10<sup>9</sup></td>
<td align="center" valign="top">5/5</td>
<td align="center" valign="top" rowspan="5">2.99&#x202F;&#x00D7;&#x202F;10<sup>7</sup></td>
</tr>
<tr>
<td align="center" valign="top">1.68&#x202F;&#x00D7;&#x202F;10<sup>8</sup></td>
<td align="center" valign="top">4/5</td>
</tr>
<tr>
<td align="center" valign="top">1.68&#x202F;&#x00D7;&#x202F;10<sup>7</sup></td>
<td align="center" valign="top">2/5</td>
</tr>
<tr>
<td align="center" valign="top">1.68&#x202F;&#x00D7;&#x202F;10<sup>6</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="center" valign="top">1.68&#x202F;&#x00D7;&#x202F;10<sup>5</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="5">&#x0394;<italic>pipC + pipC</italic></td>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>7</sup></td>
<td align="center" valign="top">5/5</td>
<td align="center" valign="top" rowspan="5">1&#x202F;&#x00D7;&#x202F;10<sup>6</sup></td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>6</sup></td>
<td align="center" valign="top">3/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>5</sup></td>
<td align="center" valign="top">1/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>4</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="center" valign="top">2&#x202F;&#x00D7;&#x202F;10<sup>3</sup></td>
<td align="center" valign="top">0/5</td>
</tr>
<tr>
<td align="left" valign="top">Blank</td>
<td align="center" valign="top">PBS</td>
<td align="center" valign="top">0/5</td>
<td align="center" valign="top">/</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec35">
<title>The deletion of <italic>pipC</italic> results in the downregulation of multiple virulence gene expression levels in <italic>SE</italic></title>
<p>To investigate the potential mechanism underlying the attenuation of <italic>SE</italic> virulence due to the deletion of the <italic>pipC</italic> gene, qPCR was employed to assess the expression levels of virulence factors. The results are presented in <xref ref-type="fig" rid="fig5">Figure 5</xref>. Compared to C50336, the expression levels of SPI-1 associated genes (<italic>invH</italic>, <italic>sipA</italic>, <italic>sipB</italic>, <italic>sipC</italic>, <italic>sopB</italic>, and <italic>sopE2</italic>) and SPI-2 associated genes (<italic>spvB</italic>, <italic>ssrA</italic>, <italic>orf245</italic>, <italic>ssaS</italic>, <italic>ssaT</italic>, <italic>ssaU</italic>, <italic>sseB</italic>, and <italic>sseD</italic>) in &#x0394;<italic>pipC</italic> were significantly decreased. These findings suggest that <italic>pipC</italic> may influence the virulence of <italic>SE</italic> by modulating the expression levels of multiple virulence genes.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The expression level of virulence genes in C50336, &#x0394;<italic>pipC</italic> and &#x0394;<italic>pipC</italic> + <italic>pipC</italic> were detected by using qPCR, with 16<italic>S rRNA</italic> as the internal reference gene. Data are presented as the mean &#x00B1; SD of three independent replicates. Statistical significance was determined as <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 (&#x002A;) and <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01 (&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g005.tif"/>
</fig>
</sec>
<sec id="sec36">
<title>The deletion of <italic>pipC</italic> reduces the colonization of <italic>SE</italic> in organs</title>
<p>The results of bacteria colonization in the liver, spleen, and cecum are shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>. All the liver, spleen and cecum samples from the blank control group were negative for <italic>Salmonella</italic> recovery. Bacteria could be isolated from the liver, spleen, and cecum at 3, 7, and 14 dpc. Compared to C50336, the counts of &#x0394;<italic>pipC</italic> in the liver, spleen, and cecum were significantly lower at 3, 7, and 14 dpc, indicating that the colonization ability of &#x0394;<italic>pipC</italic> in these organs was notably inferior to that of C50336. This suggests that the <italic>pipC</italic> gene can influence the colonization ability and virulence of <italic>SE</italic>.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>Bacterial colonization of <italic>SE</italic> in the liver, spleen, and cecum following challenge. Bacterial loads in these organs were quantified at the 3 dpc, 7 dpc, and 14 dpc, and results were expressed as log&#x2081;&#x2080;(CFU/g). Data represents the mean &#x00B1; SD from five mice. Statistical significance is indicated as <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01 (&#x002A;&#x002A;) and <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001 (&#x002A;&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g006.tif"/>
</fig>
</sec>
<sec id="sec37">
<title>&#x0394;<italic>pipC</italic> can induce immune responses</title>
<p>To elucidate the specific immune responses to <italic>SE</italic> antigens following &#x0394;<italic>pipC</italic> immunization, a splenic lymphocyte proliferation assay was performed using soluble antigens at 14 and 28 dpi. As shown in <xref ref-type="fig" rid="fig7">Figure 7A</xref>, the stimulation indices against the <italic>SE</italic> antigens for immunized group was 8.60&#x202F;&#x00B1;&#x202F;0.34 at 14 dpi. Likewise, the stimulation indices against <italic>SE</italic> antigens for immunized group was 14.07&#x202F;&#x00B1;&#x202F;0.51 at 28 dpi. The SI value of splenic lymphocytes in the immunized group was significantly higher than that in the control group, and the lymphocyte proliferation level further increased after enhanced immunization. These findings indicate that &#x0394;<italic>pipC</italic> can induce strong specific immune responses.</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p><bold>(A)</bold> The stimulation index (SI) of the splenic lymphocytes proliferation assay. Lymphocyte proliferation was measured with a MTT kit at 14 and 28 dpi. The SI was calculated using the following equation: SI&#x202F;=&#x202F;(OD<sub>570</sub> of the antigen-stimulated cells)/(OD<sub>570</sub> of the unstimulated cells). Data represent the mean &#x00B1; SD from five mice. <bold>(B,C)</bold> Antibody levels in serum and feces of KM mice following immunization. Serum and fecal samples were collected from KM mice at 14 and 28 dpi. The levels of IgG in serum and IgA in feces were determined by ELISA. Data are presented as the mean &#x00B1;SD from three independent replicates. <bold>(D,E)</bold> Cytokine expression levels in the spleen following immunization. Quantitative PCR analysis was performed to assess the mRNA expression levels of IL-1&#x03B2;, IL-2, IL-4, IL-6, IL-10, TNF-&#x03B1;, and IFN-&#x03B3; at 14 and 28 dpi. The internal control gene were gapdh and &#x03B2;-actin, respectively. Data are presented as the mean &#x00B1; SD of three independent replicates. Statistical significance was determined as <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 (&#x002A;), <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01 (&#x002A;&#x002A;) and <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001 (&#x002A;&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g007.tif"/>
</fig>
<p>To evaluate the humoral and mucosal immune responses in mice immunized with &#x0394;<italic>pipC</italic>, the serum IgG and mucosal IgA responses against <italic>SE</italic> soluble antigens were measured by ELISA. At 14 dpi and 28 dpi, mice immunized with &#x0394;<italic>pipC</italic> exhibited significantly enhanced serum IgG levels (<xref ref-type="fig" rid="fig7">Figure 7B</xref>) and secretory IgA (SIgA) levels (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) compared to the control group, with further increases observed after booster immunization. These findings indicate that &#x0394;<italic>pipC</italic> effectively induces robust specific humoral and mucosal immune responses, which are augmented with booster immunization.</p>
<p>We detected the expression of cytokines in spleen cells of immunized mice at 14 and 28 dpi. The results, shown in <xref ref-type="fig" rid="fig7">Figures 7D</xref>,<xref ref-type="fig" rid="fig7">E</xref>, revealed that at 14 dpi, the expression levels of IL-2, IL-4, IL-6, IL-10, TNF-&#x03B1;, and IFN-&#x03B3; in the &#x0394;<italic>pipC</italic> group were significantly higher than those in the control group. At 28 dpi, the expression levels of IL-2, IL-4, IL-6, IL-10, TNF-&#x03B1;, and IFN-&#x03B3; in the &#x0394;<italic>pipC</italic> group were notably higher than those in the control group. Additionally, the expression levels of IL-6 and TNF-&#x03B1; after the booster immunization were significantly higher than those after the primary immunization. The increased expression levels of cytokines highlight that &#x0394;<italic>pipC</italic> can effectively induce a strong immune response in mice.</p>
</sec>
<sec id="sec38">
<title>Immune protection by the &#x0394;<italic>pipC</italic> vaccination against virulent C50336 challenge</title>
<p>The survival percentages in the mice vaccinated orally with the &#x0394;<italic>pipC</italic> followed by the challenge with the virulent <italic>SE</italic> are shown in <xref ref-type="fig" rid="fig8">Figure 8</xref>. The vaccinated group showed no mouse deaths and a 100% survival rate; among the 10 mice in the unvaccinated group, 8 mice died after the challenge, showing a survival rate of 20%. The clinical symptoms including anorexia, chills, diarrhea, emaciation, and depression in the vaccinated group were slight and temporary after challenged compared to the unvaccinated group. Therefore, immunization with 10<sup>6</sup>&#x202F;CFU of &#x0394;<italic>pipC</italic> provided full protection against <italic>SE</italic> challenge (see <xref ref-type="fig" rid="fig9">Figure 9</xref>).</p>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p>Protective efficacy of the &#x0394;<italic>pipC</italic> following oral vaccination. KM mice were orally immunized with the &#x0394;<italic>pipC</italic> and challenged with a lethal dose of C50336 at 28 dpi. Survival was monitored daily for 14&#x202F;days after the challenge. The vaccinated group showed significantly improved survival compared to the unvaccinated group. Statistical significance was determined as <italic>p</italic> &#x003C;&#x202F;0.001 (&#x002A;&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g008.tif"/>
</fig>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>Antibody levels in serum and feces of KM mice following immunization. Serum and fecal samples were collected from KM mice at 14 and 28 days post-immunization (dpi). The levels of <bold>(A)</bold> IgG in serum and <bold>(B)</bold> IgA in feces were determined by ELISA. Data are presented as the mean &#x00B1;SD from three independent replicates. Statistical significance was assessed as <italic>p</italic> &#x003C;&#x202F;0.05 (&#x002A;), <italic>p</italic> &#x003C;&#x202F;0.01 (&#x002A;&#x002A;) and <italic>p</italic> &#x003C;&#x202F;0.001 (&#x002A;&#x002A;&#x002A;).</p>
</caption>
<graphic xlink:href="fmicb-16-1631008-g009.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec39">
<title>Discussion</title>
<p><italic>SE</italic> is a major foodborne zoonotic pathogen that poses significant economic burdens on the livestock industry and presents a serious global public health threat. The continued emergence of antimicrobial resistance (AMR), particularly multidrug resistance (MDR), in <italic>Salmonella</italic> has become a growing challenge worldwide. Vaccination has been recognized as an effective targeted strategy to control antibiotic-resistant <italic>Salmonella</italic> infections. Studies have demonstrated that vaccination significantly contributes to reducing infections caused by resistant strains (<xref ref-type="bibr" rid="ref2">Bian et al., 2024</xref>).</p>
<p>Over the years, a variety of vaccines-including inactivated and live attenuated vaccines-have been developed to combat salmonellosis. Inactivated vaccines are considered safe but generally induce weak immunogenicity, often requiring adjuvants and booster immunizations, and mainly stimulate humoral rather than cellular immunity (<xref ref-type="bibr" rid="ref20">Pan et al., 2024</xref>). In contrast, live attenuated vaccines represent a major advancement in vaccine technology by providing efficient and long-lasting protection. These vaccines use weakened but viable pathogens that are capable of eliciting strong immune responses without causing disease. A key advantage of live attenuated vaccines lies in their ability to closely mimic natural infections and engage both humoral and cell-mediated immune responses, thereby establishing robust and sustained protection (<xref ref-type="bibr" rid="ref19">Nazir et al., 2025</xref>).</p>
<p>In recent years, the use of targeted gene deletion to attenuate virulence in <italic>Salmonella</italic> has become an increasingly common strategy in vaccine development (<xref ref-type="bibr" rid="ref10">Hewawaduge et al., 2023</xref>). Given the association of <italic>pipC</italic> with host cell invasion and intracellular survival in macrophages, we constructed a <italic>pipC</italic>-deleted <italic>SE</italic> mutant using homologous recombination. Compared to the wild-type strain C50336, the &#x0394;<italic>pipC</italic> mutant exhibited significantly reduced virulence. Immunization with the &#x0394;<italic>pipC</italic> strain induced strong humoral and cellular immune responses and conferred full protection against subsequent <italic>SE</italic> challenge in mice.</p>
<p>Identification of virulence genes is essential for the rational design of live attenuated vaccines. During infection, <italic>SE</italic> faces various stress conditions--such as acid, alkali, and oxidative stress&#x2014;both in the gastrointestinal tract and within <italic>Salmonella</italic>-containing vacuoles (SCVs) of epithelial and macrophage cells. Genes involved in stress responses are often linked to virulence (<xref ref-type="bibr" rid="ref23">Pasqua et al., 2022</xref>). Our study demonstrated that deletion of <italic>pipC</italic> had no significant effect on the growth characteristics of <italic>SE</italic> under normal conditions, indicating that this gene is not essential for basic bacterial proliferation. However, the <italic>pipC</italic> mutant strain exhibited markedly reduced survival under acidic, alkaline, and oxidative stress conditions, suggesting that <italic>pipC</italic> is involved in the bacterium&#x2019;s ability to withstand environmental stress. These findings underscore the important role of <italic>pipC</italic> in stress resistance, which may, in turn, contribute to the overall virulence and persistence of <italic>SE</italic> in hostile environments.</p>
<p>Upon entering the small intestine, <italic>Salmonella</italic> first adheres to epithelial cells and invades host tissues via M cells located over Peyer&#x2019;s patches. Although macrophages within lymphoid tissues phagocytose <italic>Salmonella</italic>, the bacterium can evade destruction by interfering with phagosome-lysosome fusion, allowing it to survive and replicate intracellularly. Hence, adhesion to epithelial cells and intracellular survival in macrophages are crucial virulence determinants (<xref ref-type="bibr" rid="ref6">Eakley et al., 2011</xref>). In this study, we found that the &#x0394;<italic>pipC</italic> strain exhibited significantly reduced invasion of epithelial cells, consistent with findings by <xref ref-type="bibr" rid="ref28">Shah et al. (2011)</xref>. Additionally, intracellular proliferation was markedly impaired. A mouse intraperitoneal infection model showed that the LD&#x2085;&#x2080; of the &#x0394;<italic>pipC</italic> strain increased 47-fold compared to the wild-type strain, indicating substantial attenuation. The SPI-1 and SPI-2 pathogenicity islands encode the Type III Secretion System (T3SS), which delivers effector proteins into host cells to facilitate cytoskeletal rearrangement and invasion. Gene expression analysis further revealed that the &#x0394;<italic>pipC</italic> strain had significantly downregulated expression of several virulence-associated genes. SPI-1 genes (<italic>invH</italic>, <italic>sipA</italic>, <italic>sipB</italic>, <italic>sipC</italic>, <italic>sopB</italic>, and <italic>sopE2</italic>) and SPI-2 genes (<italic>spvB</italic>, <italic>ssrA</italic>, <italic>orf245</italic>, <italic>ssaS</italic>, <italic>ssaT</italic>, <italic>ssaU</italic>, <italic>sseB</italic>, and <italic>sseD</italic>) were all suppressed. The downregulation of these genes in the &#x0394;<italic>pipC</italic> strain implies impaired T3SS function and effector protein expression, ultimately leading to reduced invasion and virulence.</p>
<p>Live attenuated <italic>Salmonella</italic> vaccines must balance attenuation, immunogenicity, and protective efficacy. An ideal vaccine strain should be non-toxic or minimally toxic. In this study, mice infected with the &#x0394;<italic>pipC</italic> strain had significantly higher LD&#x2085;&#x2080; values and reduced colonization in the intestine, spleen, and liver compared to wild-type infections, confirming the attenuation of the mutant strain.</p>
<p>Upon entry, <italic>SE</italic> activates innate immunity, recruiting macrophages and monocytes, which secrete pro-inflammatory cytokines and promote inflammation. In parallel, B cells differentiate into effector cells, producing anti-inflammatory cytokines such as IL-10, which suppress inflammation and stimulate antibody production. Cytokines such as IFN-&#x03B3; enhance macrophage activation and help regulate immune responses (<xref ref-type="bibr" rid="ref11">Jan et al., 2022</xref>; <xref ref-type="bibr" rid="ref17">Kung et al., 2022</xref>). In our study, mice immunized with the &#x0394;<italic>pipC</italic> strain showed significantly higher splenic lymphocyte proliferation indices and serum antibody levels at both 14 dpi and 28 dpi compared to controls. Cytokine analysis revealed significantly increased expression of IL-2, IL-4, IL-6, IL-10, TNF-&#x03B1;, and IFN-&#x03B3;, indicating robust activation of both humoral and cellular immune pathways. The &#x0394;<italic>pipC</italic> strain provided complete protection (100%) against secondary wild-type challenge when administered orally at a dose of 1&#x202F;&#x00D7;&#x202F;10<sup>6</sup>&#x202F;CFU. It is important to note that we used only a single antigen concentration in our lymphocyte proliferation experiments, limiting the understanding of antigen sensitivity and cellular response thresholds. Assessment of lymphocyte response at multiple antigen concentrations should be considered in future further studies.</p>
<p>One of the main advantages of live attenuated vaccines over inactivated ones is their ability to stimulate both humoral and cellular immunity. Systemic dissemination of <italic>Salmonella</italic> promotes antigen presentation and induces specific immune responses that prevent secondary infections. Previous studies have validated the potential of gene-engineered live attenuated vaccines against <italic>Salmonella</italic>. <xref ref-type="bibr" rid="ref38">Zhao et al. (2024)</xref> showed that deletion of the <italic>pal</italic> gene attenuated <italic>SE</italic> virulence, and oral immunization with 1&#x202F;&#x00D7;&#x202F;10<sup>8</sup> CFU of &#x0394;<italic>pal</italic> conferred 100% protection against a 5&#x202F;&#x00D7;&#x202F;10<sup>6</sup> CFU wild-type challenge. <xref ref-type="bibr" rid="ref39">Zhou et al. (2023)</xref> demonstrated that deletion of <italic>rfbG</italic> increased the LD&#x2085;&#x2080; by 56-fold. Immunizing chickens with 5&#x202F;&#x00D7;&#x202F;10<sup>7</sup> or 5&#x202F;&#x00D7;&#x202F;10<sup>6</sup> CFU of &#x0394;<italic>rfbG</italic> achieved 100% survival after wild-type challenge, and significant antibody responses were observed, confirming its vaccine potential. Similarly, <xref ref-type="bibr" rid="ref21">Pan et al. (2020)</xref> reported that the LD&#x2085;&#x2080; of <italic>Salmonella Paratyphi A</italic> &#x0394;<italic>sptP</italic> was 1.43&#x202F;&#x00D7;&#x202F;10<sup>4</sup>-fold higher than the wild-type, and oral immunization with 2&#x202F;&#x00D7;&#x202F;10<sup>5</sup> CFU conferred complete protection against challenge with 1&#x202F;&#x00D7;&#x202F;10<sup>3</sup> CFU.</p>
<p>In summary, our present work demonstrates that lack of <italic>pipC</italic> affects <italic>SE</italic> pathogenicity by decreasing its virulence both <italic>in vitro</italic> and <italic>in vivo</italic>. Vaccination of mice with &#x0394;<italic>pipC</italic> conferred development of acquired immunity and efficacious protection against experimental systemic infection. The <italic>pipC</italic> mutant possesses the safety and efficacy required for use as a live attenuated vaccine. Given the potential for field applications, a more comprehensive long-term assessment of safety indicators such as fecal-shedding duration, risk of virulence re-escalation, and potential for environmental transmission is needed (<xref ref-type="bibr" rid="ref21">Pan et al., 2020</xref>). Although the &#x0394;<italic>pipC</italic> strain exhibited attenuated virulence and genetic stability under laboratory conditions, its environmental safety and stability should still be verified by field experiments before practical application, and the applicability of target animals and the safe window of vaccine dose should be systematically evaluated.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec40">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="sec41">
<title>Ethics statement</title>
<p>The animal study was approved by Experimental Animal Regulation Ordinances defined by Hebei Provincial Department of Science and Technology HPDST2020-17. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec42">
<title>Author contributions</title>
<p>LZ: Formal analysis, Writing &#x2013; original draft, Methodology, Data curation. YuC: Writing &#x2013; original draft, Formal analysis, Data curation, Methodology. ZY: Writing &#x2013; review &#x0026; editing, Funding acquisition. YuL: Methodology, Writing &#x2013; original draft. XY: Methodology, Writing &#x2013; original draft. LC: Writing &#x2013; original draft, Software. YZ: Writing &#x2013; review &#x0026; editing, Funding acquisition. YiC: Writing &#x2013; original draft, Software. YoL: Writing &#x2013; original draft, Software. QS: Funding acquisition, Writing &#x2013; review &#x0026; editing. TW: Validation, Supervision, Methodology, Writing &#x2013; review &#x0026; editing, Investigation, Writing &#x2013; original draft, Conceptualization, Funding acquisition.</p>
</sec>
<sec sec-type="funding-information" id="sec43">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by the National Key Research and Development Program (2023YFD1800701); Hebei Agriculture Research System (HBCT2024280205 and HBCT2024280406), and Shijiazhuang &#x201C;Open Challenge&#x201D; Science and Technology Project (2417908002A).</p>
</sec>
<ack>
<p>The authors thank Prof. Zhen Wang from Beijing University of Agriculture for their valuable help in our experiment.</p>
</ack>
<sec sec-type="COI-statement" id="sec44">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec45">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec46">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec47">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1631008/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1631008/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.tif" mimetype="image/tiff" xmlns:xlink="http://www.w3.org/1999/xlink" id="SM1"><label>SUPPLEMENTARY FIGURE 1</label><caption><p><bold>(A)</bold> Schematic representation of a gene knockout strategy adopted from <xref ref-type="bibr" rid="ref24">Ranallo et al. (2006)</xref>. <bold>(a)</bold> Linear DNA substrates containing chloramphenicol cassettes are generated using PCR primers with 59 bp homology (A and B) to the gene of interest (<italic>pipC</italic>). Priming from pKD3 produces linear DNA substrates. <bold>(b)</bold> These substrates introduced into bacteria made transiently hyper-recombinogenic using Gam, Beta, Exo expressed from pKD46. <bold>(c)</bold> The chloramphenicol cassette is eliminated via plasmid-based expression of a yeast derived recombinase (FLP) leaving behind an ~80 bp &#x201C;scar&#x201D; consisting of a single FRT site. <bold>(B)</bold> Schematic representation of <italic>pipC</italic>-complemented strain construction of <italic>SE</italic>.</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acevedo-Villanueva</surname> <given-names>K. Y.</given-names></name> <name><surname>Renu</surname> <given-names>S.</given-names></name> <name><surname>Shanmugasundaram</surname> <given-names>R.</given-names></name> <name><surname>Akerele</surname> <given-names>G. O.</given-names></name> <name><surname>Gourapura</surname> <given-names>R. J.</given-names></name> <name><surname>Selvaraj</surname> <given-names>R. K.</given-names></name></person-group> (<year>2021</year>). <article-title><italic>Salmonella</italic> chitosan nanoparticle vaccine administration is protective against <italic>Salmonella</italic> Enteritidis in broiler birds</article-title>. <source>PLoS One</source> <volume>16</volume>:<fpage>e0259334</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0259334</pub-id>, PMID: <pub-id pub-id-type="pmid">34784366</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Immunogenicity and cross-protective efficacy induced by delayed attenuated <italic>Salmonella</italic> with regulated length of lipopolysaccharide in mice</article-title>. <source>Gut Microbes</source> <volume>16</volume>:<fpage>2424983</fpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2024.2424983</pub-id>, PMID: <pub-id pub-id-type="pmid">39529227</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>G.</given-names></name> <name><surname>Zhao</surname> <given-names>S.</given-names></name> <name><surname>Kuang</surname> <given-names>D.</given-names></name> <name><surname>Hsu</surname> <given-names>C.-H.</given-names></name> <name><surname>Yin</surname> <given-names>L.</given-names></name> <name><surname>Luo</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Geography shapes the genomics and antimicrobial resistance of <italic>Salmonella enterica</italic> serovar Enteritidis isolated from humans</article-title>. <source>Sci. Rep.</source> <volume>13</volume>:<fpage>1331</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-022-24150-4</pub-id>, PMID: <pub-id pub-id-type="pmid">36693882</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darwin</surname> <given-names>K. H.</given-names></name> <name><surname>Robinson</surname> <given-names>L. S.</given-names></name> <name><surname>Miller</surname> <given-names>V. L.</given-names></name></person-group> (<year>2001</year>). <article-title>SigE is a chaperone for the <italic>Salmonella enterica</italic> serovar Typhimurium invasion protein SigD</article-title>. <source>J. Bacteriol.</source> <volume>183</volume>, <fpage>1452</fpage>&#x2013;<lpage>1454</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JB.183.4.1452-1454.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11157959</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname> <given-names>K. A.</given-names></name> <name><surname>Wanner</surname> <given-names>B. L.</given-names></name></person-group> (<year>2000</year>). <article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> K-12 using PCR products</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>6640</fpage>&#x2013;<lpage>6645</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id>, PMID: <pub-id pub-id-type="pmid">10829079</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eakley</surname> <given-names>N. M.</given-names></name> <name><surname>Bochsler</surname> <given-names>P. N.</given-names></name> <name><surname>Gopal Reddy</surname> <given-names>P.</given-names></name> <name><surname>Fadl</surname> <given-names>A. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Biological and virulence characteristics of the YqhC mutant of <italic>Salmonella</italic></article-title>. <source>Microbiol. Immunol.</source> <volume>55</volume>, <fpage>830</fpage>&#x2013;<lpage>840</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1348-0421.2011.00387.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22004521</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emerson</surname> <given-names>L. E.</given-names></name> <name><surname>Barker</surname> <given-names>H.</given-names></name> <name><surname>Tran</surname> <given-names>T.</given-names></name> <name><surname>Barker</surname> <given-names>S.</given-names></name> <name><surname>Enslow</surname> <given-names>S.</given-names></name> <name><surname>Ou</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Extracellular vesicles elicit protective immune responses against <italic>Salmonella</italic> infection</article-title>. <source>J. Extracell. Vesicles</source> <volume>11</volume>:<fpage>e12267</fpage>. doi: <pub-id pub-id-type="doi">10.1002/jev2.12267</pub-id>, PMID: <pub-id pub-id-type="pmid">36134734</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrari</surname> <given-names>R. G.</given-names></name> <name><surname>Rosario</surname> <given-names>D. K. A.</given-names></name> <name><surname>Cunha-Neto</surname> <given-names>A.</given-names></name> <name><surname>Mano</surname> <given-names>S. B.</given-names></name> <name><surname>Figueiredo</surname> <given-names>E. E. S.</given-names></name> <name><surname>Conte-Junior</surname> <given-names>C. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Worldwide epidemiology of <italic>Salmonella</italic> serovars in animal-based foods: a meta-analysis</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>85</volume>:<fpage>e00591-19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/AEM.00591-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31053586</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guard-Petter</surname> <given-names>J.</given-names></name></person-group> (<year>2001</year>). <article-title>The chicken, the egg and <italic>Salmonella enteritidis</italic></article-title>. <source>Environ. Microbiol.</source> <volume>3</volume>, <fpage>421</fpage>&#x2013;<lpage>430</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1462-2920.2001.00213.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11553232</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewawaduge</surname> <given-names>C.</given-names></name> <name><surname>Senevirathne</surname> <given-names>A.</given-names></name> <name><surname>Sivasankar</surname> <given-names>C.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name></person-group> (<year>2023</year>). <article-title>The impact of lipid A modification on biofilm and related pathophysiological phenotypes, endotoxicity, immunogenicity, and protection of <italic>Salmonella</italic> Typhimurium</article-title>. <source>Vet. Microbiol.</source> <volume>282</volume>:<fpage>109759</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2023.109759</pub-id>, PMID: <pub-id pub-id-type="pmid">37104940</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jan</surname> <given-names>T.-R.</given-names></name> <name><surname>Lin</surname> <given-names>C.-S.</given-names></name> <name><surname>Wang</surname> <given-names>S.-Y.</given-names></name> <name><surname>Yang</surname> <given-names>W.-Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Cytokines and cecal microbiome modulations conferred by a dual vaccine in <italic>Salmonella</italic>-infected layers</article-title>. <source>Poult. Sci.</source> <volume>102</volume>:<fpage>102373</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psj.2022.102373</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname> <given-names>H. J.</given-names></name> <name><surname>Jang</surname> <given-names>A.-Y.</given-names></name> <name><surname>Song</surname> <given-names>J. Y.</given-names></name> <name><surname>Ahn</surname> <given-names>K. B.</given-names></name> <name><surname>Han</surname> <given-names>S. H.</given-names></name> <name><surname>Bang</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Development of live attenuated <italic>Salmonella</italic> Typhimurium vaccine strain using radiation mutation enhancement technology (R-MET)</article-title>. <source>Front. Immunol.</source> <volume>13</volume>:<fpage>931052</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.931052</pub-id>, PMID: <pub-id pub-id-type="pmid">35898510</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>X.</given-names></name> <name><surname>Chu</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Gu</surname> <given-names>J.</given-names></name> <name><surname>Hong</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Preclinical evaluation of OMVs as potential vaccine candidates against <italic>Salmonella enterica</italic> serovar Enteritidis infection</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>12</volume>:<fpage>1037607</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2022.1037607</pub-id>, PMID: <pub-id pub-id-type="pmid">36389161</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamble</surname> <given-names>N. M.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Characterization and evaluation of a <italic>Salmonella enterica</italic> serotype Senftenberg mutant created by deletion of virulence-related genes for use as a live attenuated vaccine</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>23</volume>, <fpage>802</fpage>&#x2013;<lpage>812</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CVI.00233-16</pub-id>, PMID: <pub-id pub-id-type="pmid">27489135</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Meng</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>B.</given-names></name> <name><surname>Geng</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Safety and protective efficacy of <italic>Salmonella Pullorum spiC</italic> and <italic>rfaH</italic> deletion rough mutant as a live attenuated DIVA vaccine candidate</article-title>. <source>Poult. Sci.</source> <volume>101</volume>:<fpage>101655</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psj.2021.101655</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirthika</surname> <given-names>P.</given-names></name> <name><surname>Senevirathne</surname> <given-names>A.</given-names></name> <name><surname>Jawalagatti</surname> <given-names>V.</given-names></name> <name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name></person-group> (<year>2020</year>). <article-title>Deletion of the <italic>lon</italic> gene augments expression of <italic>Salmonella</italic> Pathogenicity Island (SPI)-1 and metal ion uptake genes leading to the accumulation of bactericidal hydroxyl radicals and host pro-inflammatory cytokine-mediated rapid intracellular clearance</article-title>. <source>Gut Microbes</source> <volume>11</volume>, <fpage>1695</fpage>&#x2013;<lpage>1712</lpage>. doi: <pub-id pub-id-type="doi">10.1080/19490976.2020.1777923</pub-id>, PMID: <pub-id pub-id-type="pmid">32567462</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kung</surname> <given-names>Y.-J.</given-names></name> <name><surname>Lam</surname> <given-names>B.</given-names></name> <name><surname>Tseng</surname> <given-names>S.-H.</given-names></name> <name><surname>MacDonald</surname> <given-names>A.</given-names></name> <name><surname>Tu</surname> <given-names>H.-F.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Localization of <italic>Salmonella</italic> and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity</article-title>. <source>J. Biomed. Sci.</source> <volume>29</volume>:<fpage>57</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12929-022-00841-y</pub-id>, PMID: <pub-id pub-id-type="pmid">35962391</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Z.</given-names></name> <name><surname>Tang</surname> <given-names>P.</given-names></name> <name><surname>Jiao</surname> <given-names>Y.</given-names></name> <name><surname>Kang</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Immunogenicity and protective efficacy of a <italic>Salmonella</italic> Enteritidis <italic>sptP</italic> mutant as a live attenuated vaccine candidate</article-title>. <source>BMC Vet. Res.</source> <volume>13</volume>:<fpage>194</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12917-017-1115-3</pub-id>, PMID: <pub-id pub-id-type="pmid">28646853</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nazir</surname> <given-names>J.</given-names></name> <name><surname>Manzoor</surname> <given-names>T.</given-names></name> <name><surname>Saleem</surname> <given-names>A.</given-names></name> <name><surname>Gani</surname> <given-names>U.</given-names></name> <name><surname>Bhat</surname> <given-names>S. S.</given-names></name> <name><surname>Khan</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Combatting <italic>Salmonella</italic>: a focus on antimicrobial resistance and the need for effective vaccination</article-title>. <source>BMC Infect. Dis.</source> <volume>25</volume>:<fpage>84</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12879-025-10478-5</pub-id>, PMID: <pub-id pub-id-type="pmid">39833704</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>J.</given-names></name> <name><surname>Wei</surname> <given-names>R.</given-names></name> <name><surname>Xu</surname> <given-names>P.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Ding</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Progress in the application of <italic>Salmonella</italic> vaccines in poultry: a mini review</article-title>. <source>Vet. Immunol. Immunopathol.</source> <volume>278</volume>:<fpage>110855</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetimm.2024.110855</pub-id>, PMID: <pub-id pub-id-type="pmid">39561520</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>P.</given-names></name> <name><surname>Zou</surname> <given-names>F.</given-names></name> <name><surname>He</surname> <given-names>C.</given-names></name> <name><surname>He</surname> <given-names>Q.</given-names></name> <name><surname>Yin</surname> <given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Characterization and protective efficacy of a <italic>sptP</italic> mutant of <italic>Salmonella</italic> Paratyphi A</article-title>. <source>Immun. Inflamm. Dis.</source> <volume>8</volume>, <fpage>774</fpage>&#x2013;<lpage>781</lpage>. doi: <pub-id pub-id-type="doi">10.1002/iid3.369</pub-id>, PMID: <pub-id pub-id-type="pmid">33135379</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>S.</given-names></name> <name><surname>Jung</surname> <given-names>B.</given-names></name> <name><surname>Kim</surname> <given-names>E.</given-names></name> <name><surname>Yoon</surname> <given-names>H.</given-names></name> <name><surname>Hahn</surname> <given-names>T.-W.</given-names></name></person-group> (<year>2022</year>). <article-title>Evaluation of <italic>Salmonella</italic> Typhimurium lacking <italic>fruR</italic>, <italic>ssrAB</italic>, or <italic>hfq</italic> as a prophylactic vaccine against <italic>Salmonella</italic> lethal infection</article-title>. <source>Vaccine</source> <volume>10</volume>:<fpage>1413</fpage>. doi: <pub-id pub-id-type="doi">10.3390/vaccines10091413</pub-id>, PMID: <pub-id pub-id-type="pmid">36146494</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pasqua</surname> <given-names>M.</given-names></name> <name><surname>Coluccia</surname> <given-names>M.</given-names></name> <name><surname>Eguchi</surname> <given-names>Y.</given-names></name> <name><surname>Okajima</surname> <given-names>T.</given-names></name> <name><surname>Grossi</surname> <given-names>M.</given-names></name> <name><surname>Prosseda</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Roles of two-component signal transduction systems in <italic>Shigella</italic> virulence</article-title>. <source>Biomol. Ther.</source> <volume>12</volume>:<fpage>1321</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biom12091321</pub-id>, PMID: <pub-id pub-id-type="pmid">36139160</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranallo</surname> <given-names>R. T.</given-names></name> <name><surname>Barnoy</surname> <given-names>S.</given-names></name> <name><surname>Thakkar</surname> <given-names>S.</given-names></name> <name><surname>Urick</surname> <given-names>T.</given-names></name> <name><surname>Venkatesan</surname> <given-names>M. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Developing live <italic>Shigella</italic> vaccines using &#x03BB; red recombineering</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>47</volume>, <fpage>462</fpage>&#x2013;<lpage>469</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-695X.2006.00118.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16872384</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x00ED;guez-Escudero</surname> <given-names>I.</given-names></name> <name><surname>Ferrer</surname> <given-names>N. L.</given-names></name> <name><surname>Rotger</surname> <given-names>R.</given-names></name> <name><surname>Cid</surname> <given-names>V. J.</given-names></name> <name><surname>Molina</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Interaction of the <italic>Salmonella</italic> Typhimurium effector protein SopB with host cell Cdc42 is involved in intracellular replication</article-title>. <source>Mol. Microbiol.</source> <volume>80</volume>, <fpage>1220</fpage>&#x2013;<lpage>1240</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07639.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21435037</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruvalcaba-G&#x00F3;mez</surname> <given-names>J. M.</given-names></name> <name><surname>Villagr&#x00E1;n</surname> <given-names>Z.</given-names></name> <name><surname>Valdez-Alarc&#x00F3;n</surname> <given-names>J. J.</given-names></name> <name><surname>Mart&#x00ED;nez-N&#x00FA;&#x00F1;ez</surname> <given-names>M.</given-names></name> <name><surname>Gomez-God&#x00ED;nez</surname> <given-names>L. J.</given-names></name> <name><surname>Ruesga-Guti&#x00E9;rrez</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Non-antibiotics strategies to control <italic>Salmonella</italic> infection in poultry</article-title>. <source>Animals</source> <volume>12</volume>:<fpage>102</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ani12010102</pub-id>, PMID: <pub-id pub-id-type="pmid">35011208</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rychlik</surname> <given-names>I.</given-names></name> <name><surname>Karasova</surname> <given-names>D.</given-names></name> <name><surname>Sebkova</surname> <given-names>A.</given-names></name> <name><surname>Volf</surname> <given-names>J.</given-names></name> <name><surname>Sisak</surname> <given-names>F.</given-names></name> <name><surname>Havlickova</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Virulence potential of five major pathogenicity islands (SPI-1 to SPI-5) of <italic>Salmonella enterica</italic> serovar Enteritidis for chickens</article-title>. <source>BMC Microbiol.</source> <volume>9</volume>:<fpage>268</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2180-9-268</pub-id>, PMID: <pub-id pub-id-type="pmid">20021686</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>D. H.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Addwebi</surname> <given-names>T.</given-names></name> <name><surname>Davis</surname> <given-names>M. A.</given-names></name> <name><surname>Orfe</surname> <given-names>L.</given-names></name> <name><surname>Call</surname> <given-names>D. R.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Cell invasion of poultry-associated <italic>Salmonella enterica</italic> serovar Enteritidis isolates is associated with pathogenicity, motility and proteins secreted by the type III secretion system</article-title>. <source>Microbiology</source> <volume>157</volume>, <fpage>1428</fpage>&#x2013;<lpage>1445</lpage>. doi: <pub-id pub-id-type="doi">10.1099/mic.0.044461-0</pub-id>, PMID: <pub-id pub-id-type="pmid">21292746</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>D. H.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Kim</surname> <given-names>H.-Y.</given-names></name> <name><surname>Call</surname> <given-names>D. R.</given-names></name> <name><surname>Guard</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Transposon mutagenesis of <italic>Salmonella enterica</italic> serovar Enteritidis identifies genes that contribute to invasiveness in human and chicken cells and survival in egg albumen</article-title>. <source>Infect. Immun.</source> <volume>80</volume>, <fpage>4203</fpage>&#x2013;<lpage>4215</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00790-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22988017</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tennant</surname> <given-names>S. M.</given-names></name> <name><surname>Levine</surname> <given-names>M. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Live attenuated vaccines for invasive <italic>Salmonella</italic> infections</article-title>. <source>Vaccine</source> <volume>33</volume>, <fpage>C36</fpage>&#x2013;<lpage>C41</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.04.029</pub-id>, PMID: <pub-id pub-id-type="pmid">25902362</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Upadhyaya</surname> <given-names>I.</given-names></name> <name><surname>Upadhyay</surname> <given-names>A.</given-names></name> <name><surname>Kollanoor-Johny</surname> <given-names>A.</given-names></name> <name><surname>Darre</surname> <given-names>M. J.</given-names></name> <name><surname>Venkitanarayanan</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Effect of plant derived antimicrobials on <italic>Salmonella Enteritidis</italic> adhesion to and invasion of primary chicken oviduct epithelial cells <italic>in vitro</italic> and virulence gene expression</article-title>. <source>Int. J. Mol. Sci.</source> <volume>14</volume>, <fpage>10608</fpage>&#x2013;<lpage>10625</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms140510608</pub-id>, PMID: <pub-id pub-id-type="pmid">23698782</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Qazi</surname> <given-names>I. H.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Zhou</surname> <given-names>G.</given-names></name> <name><surname>Han</surname> <given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title><italic>Salmonella</italic> virulence and immune escape</article-title>. <source>Microorganisms</source> <volume>8</volume>:<fpage>407</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms8030407</pub-id>, PMID: <pub-id pub-id-type="pmid">32183199</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>D.</given-names></name> <name><surname>Song</surname> <given-names>L.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Jiao</surname> <given-names>X.</given-names></name> <name><surname>Pan</surname> <given-names>Z.</given-names></name></person-group> (<year>2023</year>). <article-title><italic>Salmonella</italic> Enteritidis activates inflammatory storm via SPI-1 and SPI-2 to promote intracellular proliferation and bacterial virulence</article-title>. <source>Front. Cell. Infect. Microbiol.</source> <volume>13</volume>:<fpage>1158888</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2023.1158888</pub-id>, PMID: <pub-id pub-id-type="pmid">37325511</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname> <given-names>C.</given-names></name> <name><surname>Gu</surname> <given-names>J.</given-names></name> <name><surname>Gu</surname> <given-names>D.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Ji</surname> <given-names>R.</given-names></name> <name><surname>Jiao</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>The <italic>Salmonella</italic> T3SS1 effector IpaJ is regulated by ItrA and inhibits the MAPK signaling pathway</article-title>. <source>PLoS Pathog.</source> <volume>18</volume>:<fpage>e1011005</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1011005</pub-id>, PMID: <pub-id pub-id-type="pmid">36477497</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>Q.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>The <italic>mcpC</italic> mutant of <italic>Salmonella enteritidis</italic> exhibits attenuation and confers both immunogenicity and protective efficacy in mice</article-title>. <source>Front. Microbiol.</source> <volume>16</volume>:<fpage>1548920</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2025.1548920</pub-id>, PMID: <pub-id pub-id-type="pmid">39996075</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>He</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>Yu</surname> <given-names>C.</given-names></name> <name><surname>Yang</surname> <given-names>Y.</given-names></name> <name><surname>Jia</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>The impact of <italic>sseK2</italic> deletion on <italic>Salmonella enterica</italic> serovar Typhimurium virulence <italic>in vivo</italic> and <italic>in vitro</italic></article-title>. <source>BMC Microbiol.</source> <volume>19</volume>:<fpage>182</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12866-019-1543-2</pub-id>, PMID: <pub-id pub-id-type="pmid">31390974</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Wu</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name> <name><surname>Zhao</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>CheV enhances the virulence of <italic>Salmonella Enteritidis</italic>, and the Chev-deleted <italic>Salmonella</italic> vaccine provides immunity in mice</article-title>. <source>BMC Vet. Res.</source> <volume>20</volume>:<fpage>100</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12917-024-03951-x</pub-id>, PMID: <pub-id pub-id-type="pmid">38468314</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>G.</given-names></name> <name><surname>Duan</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Sun</surname> <given-names>W.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>The peptidoglycan-associated lipoprotein gene mutant elicits robust immunological defense in mice against <italic>Salmonella enteritidis</italic></article-title>. <source>Front. Microbiol.</source> <volume>15</volume>:<fpage>1422202</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2024.1422202</pub-id>, PMID: <pub-id pub-id-type="pmid">38903796</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name> <name><surname>Xiong</surname> <given-names>D.</given-names></name> <name><surname>Guo</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Kang</surname> <given-names>X.</given-names></name> <name><surname>Song</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title><italic>Salmonella Enteritidis</italic> RfbD enhances bacterial colonization and virulence through inhibiting autophagy</article-title>. <source>Microbiol. Res.</source> <volume>270</volume>:<fpage>127338</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micres.2023.127338</pub-id>, PMID: <pub-id pub-id-type="pmid">36854232</pub-id></citation></ref>
</ref-list>
</back>
</article>